Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Updated European recommendations for the clinical use of HIV drug resistance testing.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.
Virological rebound after suppression on highly active antiretroviral therapy.
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy.
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.